Developing viral vectored vaccines for MAGE-expressing tumours

Developing viral vectored vaccines for MAGE-expressing tumours

The MAGE-type antigen family represent excellent targets for a therapeutic cancer vaccine. However, numerous attempts to develop effective MAGE-targeting cancer vaccines to date have shown poor induction of specific CD8+ T-cell responses and little clinical efficacy. In this study, a novel vaccinati...

Bibliografske podrobnosti
Glavni avtor:	McAuliffe, J
Drugi avtorji:	Leung, C
Format:	Thesis
Jezik:	English
Izdano:	2020
Teme:	Tumour Immunology Experimental immunology Cancer Immunotherapy Immunology

Podobne knjige/članki

Harnessing the immune system to reject cancers through genetic modifications of tumour cells
od: Ajzensztejn, D
Izdano: (2015)

Spatial genomics uncovers cytokines promoting ovarian tumour heterogeneity and immunotherapy resistance
od: Gurkan Mollaoglu, et al.
Izdano: (2025-02-01)

Targeting the hypoxic tumour phenotype with T-cell immunotherapy
od: Chong, T
Izdano: (2004)

Immunological methods/
od: Lefkovits, Ivan, et al.
Izdano: (1990)

The role of tryptophan and the mTOR pathway in T cell fate determination
od: Karydis, I, et al.
Izdano: (2014)

The role of serine metabolism in B lymphocytes
od: Khan, A
Izdano: (2022)

Exploiting pre-existing viral immunity for B cell vaccination against endogenous antigens
od: Wong, S
Izdano: (2013)

CEA-targeted monoclonal antibody therapy in colorectal cancer
od: Conaghan, P, et al.
Izdano: (2009)

The critical role of IL-23 receptor positive T cells in the pathogenesis of anterior uveitis associated with spondyloarthropathy
od: Hedley, R
Izdano: (2021)

Antigen discrimination in primary human T cells
od: Pettmann, J
Izdano: (2021)

Targeting tumour-associated macrophages with locally-expressed T cell engagers
od: Scott, E
Izdano: (2020)

Biodegradable pulsatile release technologies for viral vector based vaccinations
od: Krastev, C
Izdano: (2018)

Directly injected lentiviral vector–based T cell vaccine protects mice against acute and chronic viral infection
od: Takuya Tada, et al.
Izdano: (2022-09-01)

Short protocols in immunology : a compendium of methods from current protocols in immunology /
od: Coligan, John E.
Izdano: (2005)

Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity
od: Christopher Cluxton, et al.
Izdano: (2023-07-01)

Remodelling of the immune landscape and its effect of tumour immunity in a model of IFNy-insensitive murine melanoma
od: Lau, VWC
Izdano: (2023)

Epithelial cell intrinsic and extrinsic effects of WNT disruption in colorectal tumorigenesis
od: Gil Vazquez, E
Izdano: (2021)

B cell responses to protein adducts
od: Deimel, LP
Izdano: (2023)

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
od: Carter, Brandon, et al.
Izdano: (2023)

Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factors
od: Ashley F. George, et al.
Izdano: (2025-01-01)

Interferon-dependent signaling is critical for viral clearance in airway neutrophils
od: Camilla Margaroli, et al.
Izdano: (2023-05-01)

Human inherited complete STAT2 deficiency underlies inflammatory viral diseases
od: Giorgia Bucciol, et al.
Izdano: (2023-06-01)

Characterising the HLA‐I immunopeptidome of plasma‐derived extracellular vesicles in patients with melanoma
od: Caitlin Boyne, et al.
Izdano: (2024-03-01)

Vaccination for hepatitis C - characterising the host immune response and its implications for a successful therapeutic vaccine
od: Halliday, J, et al.
Izdano: (2013)

The diversity of inhibitory receptor co-expression patterns of exhausted CD8+ T cells in oropharyngeal carcinoma
od: Yufang Rao, et al.
Izdano: (2024-05-01)

Investigating checkpoint inhibitor-induced gastrointestinal disease: comparisons with idiopathic ulcerative colitis and health
od: Gupta, T
Izdano: (2022)

Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
od: Marion Arnaud, et al.
Izdano: (2023-01-01)

Editorial: A new perspective of human CD8+ T cells with respect to their biology, protective and pathogenic role in anti-viral and tumor responses
od: Soumya Panigrahi, et al.
Izdano: (2023-10-01)

Southeast Asia needs a revolving fund for vaccines
od: Seraj Ahmad, Fariza Nasreen, et al.
Izdano: (2022)

Developing recombinant overlapping peptides of prostate-specific antigen as vaccine
od: Chan, S
Izdano: (2022)

Molecular mechanisms underlying the pathogenesis of dengue fever: dengue virus co-opts innate type 2 pathways to escape early control of viral replication
od: Fonseka, CL
Izdano: (2022)

Large-scale antibody immune response mapping of splenic B cells and bone marrow plasma cells in a transgenic mouse model
od: Pan, Xiaoli, et al.
Izdano: (2023)

Viral modulation of the anti-glioblastoma immune response: rewiring host immunity to recognize & kill brain cancer
od: Mihelson, N
Izdano: (2022)

Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance
od: Efeyan, Alejo, et al.
Izdano: (2020)

Characterising novel vaccine adjuvants in eliciting antigen-specific CD8+ T cell immunity
od: He, A
Izdano: (2023)

Megakaryocytes respond during sepsis and display innate immune cell behaviors
od: Frydman, Galit H., et al.
Izdano: (2023)

Generation of bispecific antibodies by structure-guided redesign of IgG constant regions
od: Iwasaki, Yordkhwan W., et al.
Izdano: (2023)

Manual of clinical laboratory immunology /
od: Rose, Noel R., et al.
Izdano: (1986)

Immunology : an illustrated outline /
od: Male, David K., 1954- author
Izdano: (2014)

Macmillan dictionary of immunology/
od: 362227 Rosen, Fred S., et al.
Izdano: (c198)